{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:02:05Z","timestamp":1784649725629,"version":"3.55.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.xcrm.2026.102908","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:43:38Z","timestamp":1782917018000},"page":"102908","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cytokine-like protein FAM3D alleviates atherosclerosis"],"prefix":"10.1016","volume":"7","author":[{"given":"Shirong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuofan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianhui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenkun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhong","family":"Xi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8832-9331","authenticated-orcid":false,"given":"Yi","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102908_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"Naghavi","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102908_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.xcrm.2026.102908_bib3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/s41569-018-0098-5","article-title":"Safety and efficacy of statin therapy","volume":"15","author":"Adhyaru","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib4","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1161\/CIRCULATIONAHA.118.034645","article-title":"Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy","volume":"138","author":"Pradhan","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib6","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","volume":"42","author":"Ginsberg","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102908_bib7","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement European Heart Journal","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102908_bib8","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib9","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1093\/eurheartj\/ehab115","article-title":"Efficacy and safety of low-dose colchicine in patients with coronary disease: a systematic review and meta-analysis of randomized trials","volume":"42","author":"Fiolet","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102908_bib10","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0140-6736(25)00055-8","article-title":"The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma","volume":"405","author":"Zaman","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102908_bib11","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41569-019-0227-9","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"16","author":"Basatemur","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib12","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.7150\/ijbs.49871","article-title":"Role of smooth muscle cells in Cardiovascular Disease","volume":"16","author":"Zhuge","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.102908_bib13","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCRESAHA.121.319722","article-title":"ADAMTS7 Knockdown in Context: Emerging Therapeutic Targets in Atherothrombosis","volume":"129","author":"Feinstein","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib14","article-title":"Targeting cytokine-like protein FAM3D lowers blood pressure in hypertension","volume":"4","author":"Shen","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.xcrm.2026.102908_bib15","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1242\/jcs.183053","article-title":"Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors","volume":"129","author":"Peng","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.xcrm.2026.102908_bib16","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1161\/ATVBAHA.118.311289","article-title":"Deficiency of FAM3D (Family With Sequence Similarity 3, Member D), A Novel Chemokine, Attenuates Neutrophil Recruitment and Ameliorates Abdominal Aortic Aneurysm Development","volume":"38","author":"He","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.102908_bib17","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1038\/s41467-020-19691-z","article-title":"FAM3D is essential for colon homeostasis and host defense against inflammation associated carcinogenesis","volume":"11","author":"Liang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102908_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155661","article-title":"Hepatocyte-secreted FAM3D ameliorates hepatic steatosis by activating FPR1-hnRNP U-GR-SCAD pathway to enhance lipid oxidation","volume":"146","author":"Hu","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/j.xcrm.2026.102908_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005549","article-title":"Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol","volume":"6","author":"Lawler","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.xcrm.2026.102908_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41569-021-00613-5","article-title":"Apolipoproteins in vascular biology and atherosclerotic disease","volume":"19","author":"Mehta","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib21","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102908_bib22","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1002\/hep.30333","article-title":"Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis","volume":"69","author":"Farrell","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102908_bib23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2020.03.010","article-title":"Cholesterol Stabilizes TAZ in Hepatocytes to Promote Experimental Non-alcoholic Steatohepatitis","volume":"31","author":"Wang","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.xcrm.2026.102908_bib24","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib25","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1161\/CIRCULATIONAHA.123.067587","article-title":"Atherosclerosis Is a Smooth Muscle Cell\u2013Driven Tumor-Like Disease","volume":"149","author":"Pan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2026.102908_bib27","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41590-018-0113-3","article-title":"Regulation of macrophage immunometabolism in atherosclerosis","volume":"19","author":"Koelwyn","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102908_bib28","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1093\/eurheartj\/ehaf337","article-title":"Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives","volume":"46","author":"Azar","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.xcrm.2026.102908_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2021.101109","article-title":"Hepatic cholesterol transport and its role in non-alcoholic fatty liver disease and atherosclerosis","volume":"83","author":"Li","year":"2021","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2011.05.014","article-title":"Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease","volume":"218","author":"Sookoian","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.xcrm.2026.102908_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.tem.2012.10.004","article-title":"Atherosclerosis: lessons from LXR and the intestine","volume":"24","author":"Bonamassa","year":"2013","journal-title":"Trends in Endocrinology & Metabolism"},{"key":"10.1016\/j.xcrm.2026.102908_bib32","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.chom.2024.04.017","article-title":"Candida albicans accelerates atherosclerosis by activating intestinal hypoxia-inducible factor2\u03b1 signaling","volume":"32","author":"Wang","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2026.102908_bib33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"Ko","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2026.102908_bib34","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1126\/science.aao6575","article-title":"A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption","volume":"360","author":"Zhang","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102908_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.28941","article-title":"Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice","volume":"65","author":"Newberry","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.xcrm.2026.102908_bib36","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.ajpath.2020.06.005","article-title":"WD40 Repeat Protein 26 Negatively Regulates Formyl Peptide Receptor-1 Mediated Wound Healing in Intestinal Epithelial Cells","volume":"190","author":"Hasegawa","year":"2020","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.xcrm.2026.102908_bib37","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1172\/JCI65569","article-title":"Formylpeptide receptor-2 contributes to colonic epithelial homeostasis, inflammation, and tumorigenesis","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102908_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s41420-021-00567-0","article-title":"Single-cell RNA-seq reveals cellular heterogeneity of mouse carotid artery under disturbed flow","volume":"7","author":"Li","year":"2021","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2026.102908_bib39","doi-asserted-by":"crossref","first-page":"1409653","DOI":"10.3389\/fendo.2024.1409653","article-title":"Triglyceride-rich lipoproteins and cardiovascular diseases","volume":"15","author":"Xu","year":"2024","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.xcrm.2026.102908_bib40","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMoa2402309","article-title":"Olezarsen for Hypertriglyceridemia in Patients at High Cardiovascular Risk","volume":"390","author":"Bergmark","year":"2024","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCULATIONAHA.118.039107","article-title":"Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia","volume":"140","author":"Ahmad","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib42","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for Homozygous Familial Hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib43","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1161\/ATVBAHA.124.321076","article-title":"ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet-Fed ApoE-\/- Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux","volume":"44","author":"Zhang","year":"2024","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.102908_bib44","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1194\/jlr.M047951","article-title":"Intestine-specific MTP and global ACAT2 deficiency lowers acute cholesterol absorption with chylomicrons and HDLs","volume":"55","author":"Iqbal","year":"2014","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.xcrm.2026.102908_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of Microsomal Triglyceride Transfer Protein in Familial Hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib46","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jacl.2016.04.013","article-title":"Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia","volume":"10","author":"Duell","year":"2016","journal-title":"J. Clin. Lipidol."},{"key":"10.1016\/j.xcrm.2026.102908_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2023.171047","article-title":"FAM3D: A gut secreted protein and its potential in the regulation of glucose metabolism","volume":"167","author":"Moser","year":"2023","journal-title":"Peptides"},{"key":"10.1016\/j.xcrm.2026.102908_bib48","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jvssci.2021.11.002","article-title":"Vascular smooth muscle cell phenotype switching in carotid atherosclerosis","volume":"3","author":"Chou","year":"2022","journal-title":"JVS. Vasc. Sci."},{"key":"10.1016\/j.xcrm.2026.102908_bib49","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-08216-z","article-title":"Spatially restricted immune and microbiota-driven adaptation of the gut","volume":"636","author":"Mayassi","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2026.102908_bib50","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/mi.2013.84","article-title":"Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1","volume":"7","author":"Alam","year":"2014","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.xcrm.2026.102908_bib51","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1172\/JCI65831","article-title":"Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair","volume":"123","author":"Leoni","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102908_bib52","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1093\/cvr\/cvab046","article-title":"Vascular smooth muscle cells in atherosclerosis: time for a re-assessment","volume":"117","author":"Grootaert","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib53","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1080\/15548627.2020.1741202","article-title":"The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting autophagy in advanced atherosclerosis","volume":"17","author":"Pi","year":"2021","journal-title":"Autophagy"},{"key":"10.1016\/j.xcrm.2026.102908_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-physiol-052824-084232","article-title":"Role of Diverse Smooth Muscle Cell Phenotypic Transitions in Atherosclerosis Development and Late-Stage Pathogenesis","volume":"88","author":"Serbulea","year":"2026","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib55","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1161\/CIRCULATIONAHA.114.014072","article-title":"ADAMTS-7 Inhibits Re-endothelialization of Injured Arteries and Promotes Vascular Remodeling Through Cleavage of Thrombospondin-1","volume":"131","author":"Kessler","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib56","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.122.061516","article-title":"Peptide Vaccine Against ADAMTS-7 Ameliorates Atherosclerosis and Postinjury Neointima Hyperplasia","volume":"147","author":"Ma","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib57","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1124\/pr.109.001578","article-title":"International union of basic and clinical pharmacology. LXXIII. nomenclature for the formyl peptide receptor (FPR) family","volume":"61","author":"Ye","year":"2009","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.xcrm.2026.102908_bib58","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.ijcard.2014.11.010","article-title":"Aspirin-triggered 15-epi-lipoxin A(4) signals through FPR2\/ALX in vascular smooth muscle cells and protects against intimal hyperplasia after carotid ligation","volume":"179","author":"Petri","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib59","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1038\/s41467-024-46336-2","article-title":"PCSK9 stimulates Syk, PKC\u03b4, and NF-\u03baB, leading to atherosclerosis progression independently of LDL receptor","volume":"15","author":"Shin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102908_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156268","article-title":"Cytokines and their role as immunotherapeutics and vaccine Adjuvants: The emerging concepts","volume":"169","author":"Rahman","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.xcrm.2026.102908_bib61","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1001\/jama.2021.21316","article-title":"Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial","volume":"326","author":"Syversen","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2026.102908_bib62","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S1470-2045(14)70319-5","article-title":"Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial","volume":"15","author":"van Rhee","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102908_bib63","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1056\/NEJMoa2201302","article-title":"Olokizumab versus Placebo or Adalimumab in Rheumatoid Arthritis","volume":"387","author":"Smolen","year":"2022","journal-title":"New Engl J Med"},{"key":"10.1016\/j.xcrm.2026.102908_bib64","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCRESAHA.123.322640","article-title":"Cardioprotective and Anti-Inflammatory Effects of FAM3D in Myocardial Ischemia-Reperfusion Injury","volume":"133","author":"Rhee","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ejphar.2017.05.010","article-title":"Animal models of atherosclerosis","volume":"816","author":"Emini Veseli","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102908_bib66","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1161\/ATVBAHA.114.303617","article-title":"Induction of Sustained Hypercholesterolemia by Single Adeno-Associated Virus\u2013Mediated Gene Transfer of Mutant hPCSK9","volume":"35","author":"Roche-Molina","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.xcrm.2026.102908_bib67","doi-asserted-by":"crossref","first-page":"H1535","DOI":"10.1152\/ajpheart.00510.2009","article-title":"Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis","volume":"297","author":"Nam","year":"2009","journal-title":"Am J Physiol-Heart C"},{"key":"10.1016\/j.xcrm.2026.102908_bib68","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2115158118","article-title":"Vitexin inhibits APEX1 to counteract the flow-induced endothelial inflammation","volume":"118","author":"Zhao","year":"2021","journal-title":"P Natl Acad Sci USA"},{"key":"10.1016\/j.xcrm.2026.102908_bib69","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.HYP.31.1.516","article-title":"Adenosine inhibits growth of human aortic smooth muscle cells via A2B receptors","volume":"31","author":"Dubey","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.xcrm.2026.102908_bib70","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1172\/JCI117016","article-title":"Long-term biological response of injured rat carotid artery seeded with smooth muscle cells expressing retrovirally introduced human genes","volume":"93","author":"Clowes","year":"1994","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102908_bib71","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/HYPERTENSIONAHA.122.20654","article-title":"Activin Receptor-Like Kinase 3 Directly Couples Galphaq (Guanine Nucleotide-Binding Protein Subunit alphaq)\/Galphaq (Guanine Nucleotide-Binding Protein Subunit alpha11) to Regulate Vascular Contractility","volume":"80","author":"Cai","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.xcrm.2026.102908_bib72","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jare.2023.10.016","article-title":"Depleting LCAT Aggravates Atherosclerosis in LDLR-deficient Hamster with Reduced LDL-Cholesterol Level","volume":"63","author":"Lin","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.xcrm.2026.102908_bib73","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1139\/y59-099","article-title":"A rapid method of total lipid extraction and purification","volume":"37","author":"Bligh","year":"1959","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.xcrm.2026.102908_bib74","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCULATIONAHA.120.053361","article-title":"Nidogen-2 Maintains the Contractile Phenotype of Vascular Smooth Muscle Cells and Prevents Neointima Formation via Bridging Jagged1-Notch3 Signaling","volume":"144","author":"Mao","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.xcrm.2026.102908_bib75","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.cell.2019.04.044","article-title":"Illuminating G-Protein-Coupling Selectivity of GPCRs","volume":"177","author":"Inoue","year":"2019","journal-title":"Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:03:08Z","timestamp":1784646188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":75,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666379126003253"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102908","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting cytokine-like protein FAM3D alleviates atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102908","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102908"}}